Xia Wang

Xia Wang

Auto-generated profile, based on publicly available information

Xia Wang

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
XWX. Wang
X. Wang
DHD. Hunter
D. Hunter
JXJ. Xu
J. Xu
CDChanghai Ding
Changhai Ding

8 March 2016 in JAMA
Verified
Journal Article
Open access
PDF file
XJXingzhong Jin
Xingzhong Jin
GJGraeme Jones
Graeme Jones
FCFlavia M. Cicuttini
Flavia M. Cicuttini
AWAnita Wluka
Anita Wluka
ZZZhaohua Zhu
Zhaohua Zhu
CDChanghai Ding
Changhai Ding
Symptomatic knee osteoarthritis occurs among 10% of men and 13% of women aged 60 years or older.1 Worldwide, knee osteoarthritis, together with hip osteoarthritis, are the 11th leading cause of global disability, accounting for 2.2% of total years lived with disability.2 Medical costs of osteoarthritis account for 1% to 2.5% of the gross domestic product in developed countries.3 Currently there are no disease-modifying therapies for osteoarthritis; therefore, there is a need to develop cost-effective approaches to prevent the development and progression of osteoarthritis.

3 November 2019 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
XWXia Wang
Xia Wang
DHDavid J. Hunter
David J. Hunter
GVGiovana Vesentini
Giovana Vesentini
DPDaniel Pozzobon
Daniel Pozzobon
MFManuela L. Ferreira
Manuela L. Ferreira
Background: To evaluate the effectiveness and safety of technology-assisted rehabilitation following total hip/knee replacement (THR/TKR). Methods: Six electronic databases were searched without language or time restrictions for relevant studies: MEDLINE, EMBASE, Cochrane Library, CINAHL, SPORTDiscus, Physiotherapy Evidence Database (PEDro); from inception to November 7th, 2018. Two reviewers independently applied inclusion criteria to select eligible randomised controlled trials (RCTs) that investigated the effectiveness of technology-based interventions, compared with usual care or no intervention for people undergoing THR/TKR. Two reviewers independently extracted trial details (e.g. patients’ profile, intervention, outcomes, attrition and adverse events). Study methodological quality was assessed using the PEDro scale. Quality of evidence was critically appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach. Results: We identified 21 eligible studies assessing telerehabilitation, game- or web-based therapy. There were 17 studies (N = 2188) in post-TKR rehabilitation and 4 studies (N = 783) in post-THR rehabilitation. Compared to usual care, technology-based intervention was more effective in reducing pain (mean difference (MD): − 0.25; 95% confidence interval (CI): − 0.48, − 0.02; moderate evidence) and improving function measured with the timed up-and-go test (MD: -7.03; 95% CI: − 11.18, − 2.88) in people undergoing TKR. No between-group differences were observed in rates of hospital readmissions or treatment-related adverse events (AEs) in those studies. Conclusion: There is moderate-quality of evidence showed technology-assisted rehabilitation, in particular, telerehabilitation, results in a statistically significant improvement in pain; and low-quality of evidence for the improvement in functional mobility in people undergoing TKR. The effects were however too small to be clinically significant. For THR, there is very limited low-quality evidence shows no significant effects.

1 February 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
XWX. Wang
X. Wang
DHDavid Hunter
David Hunter
XJXingzhong Jin
Xingzhong Jin
CDChanghai Ding
Changhai Ding

1 October 2015 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
FPFaming Pan
Faming Pan
WHWeiyu Han
Weiyu Han
XWXia Wang
Xia Wang
ZLZhenhua Liu
Zhenhua Liu
XJXingzhong Jin
Xingzhong Jin
CDChanghai Ding
Changhai Ding
Background The infrapatellar fat pad (IPFP) is of uncertain significance for knee osteoarthritis. The aim of this study was to describe the longitudinal associations between baseline IPFP maximal area and changes in knee pain, knee cartilage volume and cartilage defects in older adults. Methods 356 community-dwelling male and female adults aged 50–80 years were measured at baseline and approximately 2.6 years later. T1-weighted or T2-weighted fat-suppressed MRI was used to assess maximal IPFP area, cartilage volume and cartilage defects at baseline and/or follow-up. Knee pain was assessed by the self-administered Western Ontario McMaster Osteoarthritis Index questionnaire. Results After adjustment for confounders, IPFP maximal area in women was significantly and negatively associated with changes in knee pain (β: −0.18 to −0.86 for total knee pain, pain at night while in bed, pain when sitting/lying and pain when standing upright, all p<0.05) but not with other knee pain subscales. IPFP maximal area in women was beneficially associated with change in tibial cartilage volume per annum (β: +1.56% per cm2 at medial site; +0.86% per cm2 at lateral site, both p<0.05), but not with change in patellar cartilage volume. Further, it was significantly associated with reduced risks of increases in medial cartilage defects (relative risk: 0·46 at tibial site, relative risk: 0.59 at femoral site; both p<0.05) but not with increases at other sites in women. No significant associations were found in men. Conclusions While the associations are not fully consistent, IPFP maximal area appears to have a protective role for knee symptoms and cartilage damage in older female adults.

2 February 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LCLijian Chen
Lijian Chen
LFLijie Feng
Lijie Feng
XWXia Wang
Xia Wang
JDJian Du
Jian Du
YCYing Chen
Ying Chen
YSYuxian Shen
Yuxian Shen
Inflammation can cause endoplasmic reticulum (ER) stress and therefore activates the unfolded protein response (UPR). ER stress and the consequent UPR have the potential to activate NF-κB. However, the factors mediating the crosstalk between ER stress and the NF-κB pathway remain unclear. Here, we determined that ER stress inducible protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) was up-regulated in autoimmune diseases and inflammatory disease models. Inflammation caused MANF to relocalize to the nuclei. MANF interacted with the DNA binding domain of p65 through its C-terminal SAP-like domain in the nuclei under the condition of inflammation or ER stress. MANF consequently inhibited p65-mediated transcriptional activation by interfering with the binding of p65 to its target genes promoters. Consistently, MANF suppressed the expressions of NF-κB-dependent target genes and the proliferation of inflammatory synoviocytes. These findings suggest that MANF may be a negative regulator of inflammation and mediate the crosstalk between the NF-κB pathway and ER stress.